Patents by Inventor Janine Scott Robb

Janine Scott Robb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11332516
    Abstract: Disclosed are methods by which compounds/molecules capable of binding antigens, for example antibody type compounds/molecules, can be purified, extracted and/or selected. The methods may be used to purify, extract or select a specific type (or types) of binding agent from a mixed composition. The methods may be used to extract or purify specific binding agents from mixed compositions, which compositions comprise other agents capable of binding other antigens. The methods may find particular application as methods for the purification of blood group antigen antibodies.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: May 17, 2022
    Assignee: QBD (QS-IP) LIMITED
    Inventors: Neil Renault, Andrew Gordon Robb, Janine Scott Robb, David Cooper Robson
  • Patent number: 10613102
    Abstract: The present invention is based on the finding that red blood cell antigens can be exploited as a means to detect red blood cells/erythrocytes. Specifically, by identifying red blood cell antigens which are expressed by substantially all red blood cell types, it is possible to provide a method which achieves the reliable detection of red blood cells.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: April 7, 2020
    Assignee: QBD (QS-IP) Limited
    Inventors: Janine Scott Robb, Andrew Gordon Robb, David Cooper Robson
  • Patent number: 10161942
    Abstract: The present invention provides novel methods for the detection of antibodies, in particular, blood group antibodies. The methods of this invention may be applied to pre-transfusion blood compatibility testing for the detection of incompatibility between donor units (comprising donor red blood cells (erythrocytes)) and a recipient.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: December 25, 2018
    Assignee: QBD (QS-IP) LIMITED
    Inventors: Janine Scott Robb, David Cooper Robson, Neil Kevin Renault, Christopher Robert James Claxton
  • Publication number: 20180305442
    Abstract: Disclosed are methods by which compounds/molecules capable of binding antigens, for example antibody type compounds/molecules, can be purified, extracted and/or selected. The methods may be used to purify, extract or select a specific type (or types) of binding agent from a mixed composition. The methods may be used to extract or purify specific binding agents from mixed compositions, which compositions comprise other agents capable of binding other antigens. The methods may find particular application as methods for the purification of blood group antigen antibodies.
    Type: Application
    Filed: November 25, 2016
    Publication date: October 25, 2018
    Inventors: Neil Renault, Andrew Gordon Robb, Janine Scott Robb, David Cooper Robson
  • Publication number: 20170168075
    Abstract: The present invention provides novel methods for the detection of antibodies, in particular, blood group antibodies. The methods of this invention may be applied to pre-transfusion blood compatibility testing for the detection of incompatibility between donor units (comprising donor red blood cells (erythrocytes)) and a recipient.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 15, 2017
    Inventors: Janine Scott Robb, David Cooper Robson, Neil Kevin Renault, Christopher Robert James Claxton
  • Publication number: 20170059591
    Abstract: The present invention is based on the finding that red blood cell antigens can be exploited as a means to detect red blood cells/erythrocytes. Specifically, by identifying red blood cell antigens which are expressed by substantially all red blood cell types, it is possible to provide a method which achieves the reliable detection of red blood cells.
    Type: Application
    Filed: February 20, 2015
    Publication date: March 2, 2017
    Inventors: Janine Scott Robb, Andrew Gordon Robb, David Cooper Robson
  • Patent number: 8748355
    Abstract: The present invention relates to methods of detecting specific cell surface antigens present in a sample of cells being tested and in particular blood group antigens, which methods do not employ the addition of extrinsic labels to detect said cell surface antigens. Typically detection is carried out using an intrinsic fluorescence capability of the cells being tested.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: June 10, 2014
    Assignee: University Court of the University of Edinburgh
    Inventors: Colin Campbell, Peter Ghazal, Juraj Petrik, Janine Scott Robb
  • Publication number: 20100256005
    Abstract: An assay for the detection of antibodies to blood group antigens is provide and includes a solid substrate having immobilised thereon a fragment of cell membrane which presents a blood group antigen capable of binding to a blood group antibody. The cell fragments are preferably from red blood cells. The antigens may be immobilised in the form of an array of spots.
    Type: Application
    Filed: April 8, 2008
    Publication date: October 7, 2010
    Inventors: Juraj Petrik, Janine Scott Robb, Nichola Mary O'Looney
  • Publication number: 20080318798
    Abstract: The present invention relates to methods of detecting specific cell surface antigens present in a sample of cells being tested and in particular blood group antigens, which methods do not employ the addition of extrinsic labels to detect said cell surface antigens. Typically detection is carried out using an intrinsic fluorescence capability of the cells being tested.
    Type: Application
    Filed: March 23, 2006
    Publication date: December 25, 2008
    Inventors: Colin Campbell, Peter Ghazal, Juraj Petrik, Janine Scott Robb